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INTRODUCTION
Since estrogen plays its role through its binding to estro-
gen receptors (ERs), ER- and ER- , the morphological
information on the distribution of ERs became imperative
in understanding the effect of estrogen on various intracel-
lular molecular dynamics. Among various organs exhibiting
ER immunoreactivities (IRs), the central nervous system
(CNS) was intensively investigated because estrogen was
recently revealed to be crucial for neuroprotective functions
(1-3). These novel functions of estrogen in the CNS were
reported to be related to the presence of ERs within the cyto-
plasm (4-6), which were quite different from those of previ-
ously recognized ERs in the nuclei of cells (7-10). Among
the neural cells showing possible estrogen-related neuropro-
tective effect, astrocytes were important candidates for the
function because ER- IRs were shown to be intensely local-
ized within astrocytes of affected brain regions in some patho-
logical states. ER- was exclusively localized within astro-
cytes exhibiting glial fibrillary acidic protein (GFAP) or vi-
mentin IRs, the markers for reactive astrocytes against vari-
ous injuries to the brain (11). In this regard, reactive astro-
cytes could be a direct target for estrogens working through
its binding to ERs within the cells. Taken together, ER-
IRs were mainly observed in neurons in normal state but
ER- IRs shifted into astrocytes in some pathological states.
However, we found out that ER- IRs were expressed dif-
ferentially even among GFAP-positive astrocytes, suggesting
that the expression of ER- IRs might affect the expression
of GFAP and even the process elongation of astrocytes. The
findings of this study also suggests that the expression pat-
tern of ER- IRs in reactive astrocytes under neuropathlogical
conditions could be more complicated than have been sug-
gested by previous studies.
CASE REPORT
The subject of the current case, human female neonate,
was born at 41 weeks of gestation by cesarean section. After
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Reactive Astrocytes Expressing Intense Estrogen Receptor-alpha
Immunoreactivities Have Much Elongated Cytoplasmic Processes: An
Autopsy Case of Human Cerebellar Tissue with Multiple Genitourinary
and Gastrointestinal Anomalies
We performed an immunohistochemical study on the estrogen receptor alpha (ER- )
distribution in the cerebellum of a human neonate with multiple congenital anoma-
lies, that had been acquired during autopsy. Although the exact pathology in the
brain was not clearly elucidated in this study, an unidentified stressful condition
might have induced the astrocytes into reactive states. In this immunohistochemi-
cal study on the neonatal cerebellum with multiple congenital anomalies, intense
ER- immunoreactivities (IRs) were localized mainly within the white matter even
though ER- IRs were known to be mainly localized in neurons. Double immuno-
histochemical staining showed that ER- IR cells were reactive astrocytes, but not
neurons. Interestingly, there were differences in the process length among the reac-
tive astrocytes showing ER- IRs. Our quantitative data confirmed that among the
glial fibrillary acidic protein (GFAP)-expressing reactive astrocytes, the cells exhibit-
ing intense ER- IRs have much longer cytoplasmic processes and relatively wea-
ker GFAP IRs. Taken together, the elongated processes of reactive astrocytes
might be due to decreased expression of GFAP, which might be induced by ele-
vated expression of ER- even though the elucidation of the exact mechanism
needs further studies.
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she died on the sixth postnatal day, autopsy was performed.
The postmortem examination showed various anomalies of
cardiovascular, digestive, and urogenital systems. The anoma-
lies included patent ductus arteriosus, pyrolic stenosis of the
stomach, exstrophy of the urinary bladder, urethral atresia,
omphalocele-containing urinary bladder, vaginal atresia (com-
plete obstruction), and anorectal agenesis with rectovesical
fistulas. However, no specific morphological anomalies were
detected in the brain by gross and microscopic examinations.
The cerebellar tissue sample was taken and immersed over-
night in the freshly prepared 4% paraformaldehyde (PFA)-
containing phosphate-buffered saline (PBS). Subsequent tis-
sue processing and immunohistochemical study were per-
formed in accordance with our previous method (12). The
primary antibodies used in the present study were rabbit
anti-human ER- antibody (1:1,000, Santa Cruz, CA, U.S.A.),
mouse anti-GFAP antibody (1:500, Biogenix, CA, U.S.A.),
mouse anti-OX42 antibody (MCA275G, SeroTec, U.K.),
and mouse monoclonal anti-165 kDa neurofilament (1:500,
Developmental Studies Hybridoma Bank, Iowa, U.S.A.)
antibody. The secondary antibodies used for fluorescence
microscope were alexa fluor 555, and alexa fluor 488 anti-
bodies against rabbit and mouse (Molecular Probes, Eugene,
OR). DAPI (1:5,000, Molecular Probes) was used for nucle-
us staining.
Intense ER- IRs were observed mainly within the white
matter than those in the gray matter including granular and
molecular layers (Fig. 1A, B). To rule out the possibility that
ER- IRs were expressed by cerebellar neurons, double im-
munohistochemical staining was performed with anti-ER-
and anti-165 kDa neurofilament antibodies. Anti-165 kDa
neurofilament IRs were not co-localized in the cell processes
exhibiting ER- IRs (Fig. 1C). 
The types of ER- -positive cells were also identified by a
double immunohistochemical study with both anti ER-
and GFAP antibodies. The majority of the cells expressing
ER- IRs showed GFAP IRs (Fig. 2A to C). And there
might be some differences in the process length among the
reactive astrocytes showing both GFAP and ER- IRs. The
reactive astrocytes with intense ER- IRs exhibited relative-
ly long processes and relatively weak GFAP IRs (Fig. 3). To
confirm this pattern with a statistical method, the reactive as-
trocytes exhibiting GFAP IRs were classified into two groups;
the one with long processes (>20  m of process length) and
the other with short processes (below 20  m of process le-
ngth). The intensities of GFAP IRs and ER- IRs were also
differentially measured in perinuclear or process areas within
the cells in each group. The signal intensities were measured
in 100 different photographed fields using Image program
(Scion Corporation, Frederick, MD, U.S.A.). All densitometric
Fig. 1. (A) and (B) Estrogen receptor alpha (ER- ) immunoreac-
tivities (IRs) in the cerebellum of a human neonate with multiple
congenital anomalies. (B) is the magnified image of (A). W, white
matter; Gr, granular layer; M, molecular layers. Yellow arrows
indicate ER- IR cells exhibiting extended processes around all
directions. (C) Double immunohistochemical study using anti-
neurofilament and anti-ER- antibodies in the cerebellum of the
human neonate with multiple congenital anomalies. Neurofilament
IRs (green, indicated by white arrows); ER- IRs (red); Nuclei
stained with DAPI (blue). Scale Bars, 40  m. 
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data were expressed as mean density, i.e. the average of the
gray values of all pixels within the measured area (maximum
level is 256). The acquired data were analyzed by Student t-
test, and a p value less than 0.01 was deemed statistically sig-
nificant. The final data were presented as means±S.D. In this
quantitative study, we statistically confirmed that GFAP im-
munoreactive astrocytes with long processes expressed much
intense ER- IRs than those with short processes (Fig. 4).
ER- IR cells were not reactive for a microglia marker, OX-
42 (Fig. 5).
DISCUSSION
It was well known that ER- was mainly expressed by neu-
rons in the brain without any neuropathological findings
(13-15). On the other hand, we showed that much intense
ER- IRs were observed mainly within astrocytes of the white
matter than neurons in the gray matter of the neonatal cere-
bellum with multiple congenital anomalies of the present case.
Since ER- was known to be localized within astrocytes in
cases of excitotoxic injury or Alzheimer disease (11, 16), the
current study could be well matched with previous reports.
Therefore, even though the exact neuropathology of the cur-
rent case was not clearly revealed in this study, the abnormal
expression pattern of ER- , the decreased intensities of neu-
ronal ER- IRs and increased intensities of ER- IRs in astro-
cytes, could suggest that the neonatal brain might be under
abnormal neurological conditions, which might finally induce
the astrocytes into reactive states. 
Though we could not be sure if estrogen directly affect
the elongation of the astrocyte processes, it should be also
considered that estrogen might inhibit GFAP transcription
in astrocytes, which in turn down-regulate the proliferation
of reactive astrocytes after injury (17). 
As to the another possible cause of process elongation of
Fig. 2. Double immunohistochem-
ical study on the cell type of est-
rogen receptor-alpha (ER- ) im-
munoreactivity (IR) cells in the ce-
rebellum of a human neonate with
multiple congenital anomalies. (A)
for anti-glial fibrillary acidic protein
(GFAP); (B) for anti-ER- antibod-
ies; (C) is the merged image of
(A) and (B). Intensely ER- IR as-
trocytes with longer processes
were encircled by white dotted
line. Astrocytes with weaker ER-
IRs were encircled by a yellow
dotted line. Scale bars, 20  m.
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ER- -positive reactive astrocytes, the previous report on the
effect of estrogen on promoting neurite sprouting under
nerve growth factor (NGF) stimulation (18) deserves con-
sideration. According to them, estrogen treatment marked-
ly enhanced NGF-stimulated neurite outgrowth of PC12
cells that were stably transfected with the full-length rat
ER- gene (PCER). Since the estrogen effect on the neurite
sprouting was thought to be correlated with the modulated
expression of various cytoskeletal proteins (18), we could
suggest the possibility that estrogen might also affect the
cytoskeleton dynamics through ER- during the process
elongation of reactive astrocytes. 
Although we could not clearly elucidate the cause of pro-
cess elongation in ER- IR astrocytes currently, the present
study demonstrated for the first time that among reactive
Fig. 3. Comparison of reactive astrocytes
with short (A, B) and long processes (C,
D). (A) and (C) for glial fibrillary acidic
protein (GFAP) immunoreactivities (IRs).
(B) and (D) for estrogen receptor alpha
(ER- ) IRs. Scale bars, 20  m.  A B
C D
GFAP
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Fig. 4. Quantitative analysis on the relationship between the process
length and the intensities of ER- or GFAP IRs of reactive astrocy-
tes. A pvalue of less than 0.01 was deemed statistically significant. 
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astrocytes under abnormal conditions, cells that express
ER- intensely had much longer processes, which might
have been caused by the decrease in GFAP expression or
inducing effect of estrogen on cytoskeleton dynamics. How-
ever, since our findings were from a single case under un-
known pathological stimuli, our hypothesis should be con-
sidered as a tentative suggestion until the general mecha-
nism related to the current changes could be further eluci-
dated in the forthcoming animal experiments. 
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